Clinical Trial Update: Study of CS-3150 in Patients With Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for CS-3150 in patients with essential hypertension has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• CS-3150 (CS-3150)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED